Is Park Medi World Ltd (PARKHOSPS) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Park Medi World Ltd is a below average quality company .

Is Park Medi World Ltd (PARKHOSPS) undervalued or overvalued?

The key valuation ratios of Park Medi World Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Park Medi World Ltd (PARKHOSPS) share price return in the past 10 years?

Data is not available for this company

Is Park Medi World Ltd (PARKHOSPS) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Park Medi World Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

What is the share price of Park Medi World Ltd (PARKHOSPS)?

Company share prices are keep on changing according to the market conditions. The current trading price of Park Medi World Ltd (PARKHOSPS) on 17-Apr-2026 16:59:59 at 16:59 is 216.20.

What is the P/E ratio of Park Medi World?

The latest standalone P/E ratio of Park Medi World as of 17-Apr-2026 is 1300.79.

What is the P/B ratio of Park Medi World Ltd (PARKHOSPS)?

The latest standalone P/B ratio of Park Medi World Ltd (PARKHOSPS) as of 17-Apr-2026 is 10.39.

What is the 52-week high and low of Park Medi World Ltd (PARKHOSPS)?

The 52-week high of Park Medi World Ltd (PARKHOSPS) is Rs. 217.95 and the 52-week low is Rs. 138.15.

Park Medi World Ltd (PARKHOSPS) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Park Medi World Ltd (PARKHOSPS)
Brand: Park Medi World

Park Medi World Ltd (PARKHOSPS) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Park Medi World Ltd (PARKHOSPS)

BSE: 544645 NSE: PARKHOSPS

Key Metrics

Market Cap

₹9,338 Cr.

P/E Ratio

1300.79

Price to Book (P/B)

10.39

Price to Sales (P/S)

101.97

EV/EBITDA

362.06

Return on Capital Employed (ROCE)

8.47%

Current Price

₹216.2

Return on Equity (ROE)

6.51%

Return on Assets (ROA)

2.42%

Operating Profit Margin

26.4%

Net Profit Margin

7.84%

Gross Profit Margin

15%

Book Value per Share

₹20.8

Sales Growth (YoY)

2.26%

Sales Growth (3 Years)

-5.91%

Operating Profit Growth (1 Year)

-6.07%

Operating Profit Growth (3 Years)

5.26%

Net Profit Growth (1 Year)

-4.27%

52-Week Low / High

₹138 / 218

Net Profit Growth (3 Years)

-55.87%

Dividend Yield

0.00%

Promoter Holding

82.89%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Park Medi World Ltd?

Park Medi World Ltd revenue growth is 2.3% for FY-2025 , which is above its 5 year CAGR of 0% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Park Medi World Ltd?

Promoters hold 82.89% of the Park Medi World Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Park Medi World Ltd vs industry peers?

Park Medi World Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 1.49% , indicating stable growth and maintaining its market share.

Q.1 Which industry/sub-sector does Park Medi World Ltd belong to?

Park Medi World Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.

Q.1 Stock return of Park Medi World Ltd over the last decade?

Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

DeciZen - make an informed investing decision on Park Medi World

Based on:

Data

Overall Rating ⓘ
Login to view analysis.

1. Quality

2. Valuation

3. Price Trend

Park Medi World stock performance

Key Ratios

Is Park Medi World Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	16.6%	11.6%	11.8%	8.5%	-
Value Creation Index ⓘ	0.2	-0.1	-0.1	-0.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	110	102	89.6	91.6	92
Sales YoY Gr.	-	-6.8%	-12.6%	2.3%	-
Adj EPS ⓘ	0.2	0.2	0.2	0.2	0.2
YoY Gr.	-	-13.6%	5.3%	-5%	-
BVPS (₹) ⓘ	2.5	2.6	2.8	3	20.8
Adj Net Profit ⓘ	8.4	7.1	7.5	7.2	7
Cash Flow from Ops. ⓘ	29.5	45.4	48.1	9.3	-
Debt/CF from Ops. ⓘ	3.3	2.5	2.6	17	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	-5.9%	2.3%
Adj EPS ⓘ	NA	NA	-4.8%	-5%
BVPSⓘ	NA	NA	5.4%	7.2%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	8.6	7.2	7.3	6.6	1.4
Op. Profit Mgn % ⓘ	18.8	23.4	28.8	26.4	33.1
Net Profit Mgn % ⓘ	7.6	6.9	8.4	7.9	8
Debt to Equity ⓘ	1	1.1	1.2	1.4	-
Working Cap Days ⓘ	0	294	235	178	0
Cash Conv. Cycle ⓘ	0	84	33	14	0

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	0.2	4.8
TTM Sales (₹ Cr.)	91.6	1,394
BVPS (₹) ⓘ	20.8	43.5
Reserves (₹ Cr.) ⓘ	812	1,794
P/BV ⓘ	10.39	4.97
PE ⓘ	1300.79	45.52

From the Market
52 Week Low / High (₹)	138.15 / 217.95
All Time Low / High (₹)	138.15 / 217.95
Market Cap (₹ Cr.)	9,338
Equity (₹ Cr.)	86.4
Face Value (₹)	2
Industry PE ⓘ	86.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Park Medi World - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'22	Mar'23	Mar'24	Mar'25
Sales	110	102	90	92
Operating Expenses ⓘ +	89	78	64	67
Manufacturing Costs	21	4	17	16
Material Costs	20	19	15	16
Employee Cost	15	18	16	17
Other Costs ⓘ	33	38	17	18
Operating Profit ⓘ	21	24	26	24
Operating Profit Margin (%)	18.8%	23.4%	28.7%	26.4%
Other Income ⓘ +	15	5	5	2
Exceptional Items ⓘ	0	0	0	0
Interest ⓘ	20	13	14	12
Depreciation ⓘ	3	5	5	5
Profit Before Tax ⓘ	13	10	13	9
Tax ⓘ	4	3	5	2
Profit After Tax	8	7	7	7
PAT Margin (%)	7.6%	6.9%	8.4%	7.8%
Adjusted EPS (₹)	0.2	0.2	0.2	0.2
Dividend Payout Ratio (%)	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	98	100	106	114
Share Capital ⓘ	77	77	77	77
Reserves ⓘ	21	24	30	37
Debt +	88	99	117	145
Long Term Debt	75	35	34	50
Short Term Debt	13	64	83	94
Minority Interest	0	0	0	0
Trade Payables	6	10	14	15
Others Liabilities ⓘ	37	64	39	44
Total Liabilities ⓘ	229	273	277	317
Fixed Assets
Net Fixed Assets ⓘ +	20	34	73	75
Gross Block	44	39	82	89
Accumulated Depreciation	24	5	9	14
CWIP ⓘ	8	5	13	37
Investments ⓘ	102	148	149	149
Inventories	0	0	0	0
Trade Receivables	44	36	22	33
Cash Equivalents	11	9	4	6
Others Assets ⓘ	43	42	16	18
Total Assets ⓘ	229	273	277	317

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	30	45	48	9
PBT ⓘ	13	10	13	9
Adjustment ⓘ	10	14	15	21
Changes in Working Capital ⓘ	12	30	24	-20
Tax Paid ⓘ	-5	-9	-3	-0
Cash Flow From Investing Activity ⓘ +	-21	-39	-51	-31
Capex	-19	1	-51	-33
Net Investments	-15	-42	-5	1
Others ⓘ	13	2	5	1
Cash Flow From Financing Activity ⓘ +	-9	-1	-5	24
Net Proceeds from Shares ⓘ	0	0	0	0
Net Proceeds from Borrowing ⓘ	19	-40	-7	21
Interest Paid ⓘ	-20	-13	-14	-7
Dividend Paid ⓘ	0	0	0	0
Others ⓘ	-8	53	16	9
Net Cash Flow ⓘ	-0	5	-8	1

Finance Ratio

PARTICULARS	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	8.55	7.18	7.25	6.51
ROCE (%)	16.57	11.55	11.76	8.47
Asset Turnover Ratio	0.48	0.41	0.33	0.31
PAT to CFO Conversion(x)	3.75	6.43	6.86	1.29
Working Capital Days
Receivable Days	147	142	118	111
Inventory Days	1	0	0	0
Payable Days	114	160	299	321

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Park Medi World Ltd FAQs

The current trading price of Park Medi World on 17-Apr-2026 16:59 is ₹216.2.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Park Medi World stood at ₹9,338.4 Cr

The latest P/E ratio of Park Medi World as of 16-Apr-2026 is 1,300.8.

The latest P/B ratio of Park Medi World as of 16-Apr-2026 is 10.39.

The 52-week high of Park Medi World is ₹217.9 and the 52-week low is ₹138.2.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Park Medi World is ₹91.58 ( Cr.) .

About Park Medi World Ltd

Park Medi World was incorporated in New Delhi as ‘Park Medi World Private Limited’ as a private limited company on January 20, 2011. Subsequently, the company was converted to a public limited company and the name of the company has been changed to the present name, ‘Park Medi World Limited’, pursuant to a resolution passed by the board on November 15, 2024 and by the shareholders on November 18, 2024.

The company is one of the largest private hospital chains in North India. It offers multiple super specialty and specialty services, including internal medicine, neurology, urology, gastroentereology, general surgery, orthopedics and oncology. It operates a network of NABH accredited multi-super specialty hospitals under the ‘Park’ brand, of which some hospitals are also NABL accredited. The company has adopted a cluster-based approach to grow its network of hospitals leveraging the benefits of proximity between its hospitals leading to operational efficiencies and enabling it to benefit from economies of scale.

In order to ensure that its services remain affordable, the company actively pursue several strategic measures to manage its operating costs. These include employing modern medical technology to reduce recovery time, employing full-time doctors and consultants, nurses and medical staff, maintaining strong relationships with its vendors and leveraging economies of scale from its existing network. The company is led by its founder and Chairman Ajit Gupta, whose leadership and deep understanding of the healthcare landscape in India has laid the foundation for the company’s growth.

Business area of the company

The company, along with its subsidiaries, is in the business of owning, managing and running medical facilities in order to provide comprehensive services and to undertake research including clinical research and development work required to promote, assist or engage in setting up hospitals.

Services of the company

Internal Medicine
Neurology
Urology
Gastroenterology
Cardiology
General Surgery
Orthopedic
Oncology
Other specialty service

Awards, accreditations and recognition

2017: Indian Excellence Award for ‘Best Multi-Specialty Hospital in Delhi-NCR and Haryana’ in ‘Healthcare & Business Sector’ was awarded to Park Hospital.
2019: Healthcare Leadership Award for ‘Best Multi Super Speciality Hospital’ was awarded to Park Hospital, Gurgaon.
2019: Award for ‘Most Valuable and Admirable Hospital’ was awarded to Park group of Hospitals by ET Now.

History and milestones

2011: Incorporation of the company on January 20, 2011.
2011: Took over the running proprietorship business of Park Sunil Hospital, Delhi and/or Park Hospital, New Delhi from one of the Promoters, Ajit Gupta.
2011: The company acquired Aggarwal Hospitals and Research Services Private Limited.
2017: The company’s subsidiary, Park Medicenters acquired DMR Hospitals Private Limited.
2020: The company acquired Blue Heavens Health Care Private Limited.
2020: The company’s subsidiary, Kailash Super-Speciality Hospital Private Limited acquired 100% running business of ‘Kailash Hospital Behror’.
2021: The company acquired Umkal Health Care Private Limited.
2021: The company’s subsidiary, Park Medicity India Private Limited acquired Narsingh Hospital & Heart Institute Private Limited.
2022: The company’s subsidiary, Park Medicenters & Institutions Private Limited acquired Ratangiri Innovations Private Limited.
2023: The company’s subsidiary, Park Medicenters & Institutions Private Limited acquired R G S Healthcare Limited.
2025: The company’s subsidiary, Aggarwal Hospitals and Research Services Private Limited acquired 55.00% share capital Devina Derma Private Limited.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Park Medi World Ltd (PARKHOSPS) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Park Medi World Share Price